ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : Genes Microarray
Scheme : NHMRC Project Grants
Clear All
Filter by Field of Research
Medical and Health Sciences (14)
Oncology And Carcinogenesis (14)
Genetic Development (Incl. Sex Determination) (13)
Genetics Not Elsewhere Classified (8)
Neurogenetics (8)
Gene Expression (7)
Allergy (5)
Oncology and Carcinogenesis (5)
Cell Development, Proliferation and Death (4)
Endocrinology (4)
Gastroenterology and Hepatology (4)
Nutrigenomics and personalised nutrition (4)
Protein Targeting And Signal Transduction (4)
Quantitative Genetics (4)
Respiratory Diseases (4)
Developmental Genetics (incl. Sex Determination) (3)
Genetics (3)
Medical Genetics (3)
Reproduction (3)
Sport and exercise nutrition (3)
Biochemistry and Cell Biology (2)
Cancer Genetics (2)
Cell Development (Incl. Cell Division And Apoptosis) (2)
Clinical chemistry (incl. diagnostics) (2)
Clinimetrics (2)
Genetic Immunology (2)
Haematology (2)
Humoural immunology and immunochemistry (2)
Medical Parasitology (2)
Psychiatry (incl. Psychotherapy) (2)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (213)
Filter by Status
Closed (213)
Filter by Scheme
NHMRC Project Grants (213)
Filter by Country
Australia (7)
Filter by Australian State/Territory
VIC (4)
QLD (3)
WA (2)
TAS (1)
  • Researchers (0)
  • Funded Activities (213)
  • Organisations (37)
  • Funded Activity

    Molecular Cascades Determining Asexual-sexual Development In Echinococcus Granulosus

    Funder
    National Health and Medical Research Council
    Funding Amount
    $312,576.00
    Summary
    Hydatid disease is a zoonosis caused by the dog tapeworm Echinococcus with millions of people-animals infected. After decades of study, effective treatment remains a major challenge. We will use a combination of recently developed techniques to isolate specific genes associated with Echinococcus differentiation. Understanding how these genes are controlled will increase our sparse knowledge of the developmental biology of this important parasite and provide new clues for more effective therapies
    More information
    Funded Activity

    Tumour Suppressor Genes In PNET Pathogenesis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $425,250.00
    Summary
    Primary central nervous system (CNS) tumours, arising in the brain and spinal cord, are the leading cause of cancer-related deaths in children less than 15 years of age. Medulloblastomas and other primitive neuroectodermal tumours (PNETs) are the most common form of primary childhood brain tumours, accounting for 25-30% of cases. Despite notable recent advances in our understanding of the molecular genetic basis of malignancies, the pathogenesis of CNS PNETs remains obscure. To address this prob .... Primary central nervous system (CNS) tumours, arising in the brain and spinal cord, are the leading cause of cancer-related deaths in children less than 15 years of age. Medulloblastomas and other primitive neuroectodermal tumours (PNETs) are the most common form of primary childhood brain tumours, accounting for 25-30% of cases. Despite notable recent advances in our understanding of the molecular genetic basis of malignancies, the pathogenesis of CNS PNETs remains obscure. To address this problem, we propose to apply a novel combinatorial approach for the identification of PNET tumour suppressor genes utilising both representational difference analysis (RDA) and microarray expression profiling. Data from this study will help to elucidate the molecular pathways that are compromised in the initiation and growth of PNETs. This information will have direct implications for the development of improved diagnostic and prognostic indicators necessary for the design of more effective therapeutic strategies for the treatment of PNET patients.
    Read more Read less
    More information
    Funded Activity

    The Molecular Biology Of Gonad Development

    Funder
    National Health and Medical Research Council
    Funding Amount
    $835,710.00
    More information
    Funded Activity

    Identification Of Breast And Ovarian Tumour Suppressor Genes On Chromosome 22 By Functional Complementation

    Funder
    National Health and Medical Research Council
    Funding Amount
    $249,250.00
    Summary
    Cancer is fundamentally a genetic disease that arises when errors (mutations) accumulate in genes involved in regulating how and when cells grow. An important class of gene involved in this process are the tumour suppressors whose primary function is to inhibit cell growth. It is widely believed that significant improvements in the treatment and diagnosis of cancer will only be achievable once we have a detailed understanding of how these genes work. It is likely that dozens of tumour suppressor .... Cancer is fundamentally a genetic disease that arises when errors (mutations) accumulate in genes involved in regulating how and when cells grow. An important class of gene involved in this process are the tumour suppressors whose primary function is to inhibit cell growth. It is widely believed that significant improvements in the treatment and diagnosis of cancer will only be achievable once we have a detailed understanding of how these genes work. It is likely that dozens of tumour suppressor genes exist in the human genome and of these only a small proportion have been identified. The aim of this study is to identify genes on human chromosome 22 that are involved in the development of breast and ovarian cancer. Genetic evidence from many investigators, including data from our own laboratory, has indicated that multiple tumour suppressor genes are present on human chromosome 22 but as yet none have been positively identified. Part of the difficulty in identifying these genes is that cancer cells often have a lot of genetic damage and it is hard to distinguish the important changes from background genetic noise'. To circumvent this problem we are using a functional cloning approach which identifies tumour suppressor genes by their ability to inhibit the growth of cancers cells grown in culture in the laboratory. Genes that are identified in this way will be evaluated for the presence of genetic mutations in real human cancers which will give us a better idea of their true significance in tumour development. In addition to enhancing our understanding of the process tumour development this project may identify new targets for anti-cancer therapies.
    Read more Read less
    More information
    Funded Activity

    Differential Gene Expression Analysis To Elucidate The Mechanisms Of Thymic Development

    Funder
    National Health and Medical Research Council
    Funding Amount
    $153,661.00
    More information
    Funded Activity

    Chlamydial Disease Pathogenesis And Diagnosis - Identification Of Stage-specific Genes

    Funder
    National Health and Medical Research Council
    Funding Amount
    $169,374.00
    More information
    Funded Activity

    Body Segment Identity Specification By The Transcription Regulator, Moz

    Funder
    National Health and Medical Research Council
    Funding Amount
    $366,301.00
    Summary
    One in 28 newborns have birth defects. Cleft palate and aortic arch defects are among the most common, always requiring surgery and often causing lethality. We propose to study a protein, Moz, which is essential for palate and aortic arch development. Moz (Monocytic leukaemia zinc finger protein) was first identified in human chromosomal abnormalities causing particularly aggressive forms of childhood and adult leukaemia. We have shown previously that Moz is essential for the formation of blood .... One in 28 newborns have birth defects. Cleft palate and aortic arch defects are among the most common, always requiring surgery and often causing lethality. We propose to study a protein, Moz, which is essential for palate and aortic arch development. Moz (Monocytic leukaemia zinc finger protein) was first identified in human chromosomal abnormalities causing particularly aggressive forms of childhood and adult leukaemia. We have shown previously that Moz is essential for the formation of blood stem cells. Moz can regulate the activity of genes, but which genes it regulates in vivo is unknown. In the absence of Moz, mice are born with a cleft palate, lack the thymus, where immune cells are instructed, and fail to form the lung blood circulation, so that they are unable to supply their blood with oxygen after birth. Moz deficiency also causes defects of the vertebrate column, such that individual vertebrae acquire the appearance of their neighbours. These symptoms are typical for a general defect in positional information of individual body segments with respect to their location along the body axis. We will investigate the molecular mechanisms that require Moz in patterning of the body axis. This project will characterize a genetic mechanism that is crucial for normal development of the palate, the aorta and the vertebrate column.
    Read more Read less
    More information
    Funded Activity

    A Genome-wide Association Study Of Endometrial Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $1,066,328.00
    Summary
    Endometrial cancer (uterine-womb cancer) is the most common invasive gynaecological cancer in Australia. Each year more than 1400 women are affected by the condition. The non-biased approach of our large study will identify genes that increase risk of this cancer, to provide information for future targeted therapies to prevent progression, and large-scale studies investigating how these genes interact with environmental factors such as hormone replacement therapy and obesity to cause disease.
    More information
    Funded Activity

    The Molecular Characterization Of Transplantation Antig Ens In Aborigines

    Funder
    National Health and Medical Research Council
    Funding Amount
    $133,993.00
    More information
    Funded Activity

    Target Genes And Effects On Cell Survival Of The Myb Oncoprotein In Myeloid Cells

    Funder
    National Health and Medical Research Council
    Funding Amount
    $166,408.00
    More information

    Showing 1-10 of 213 Funded Activites

    • 1
    • 2
    • 3
    • 4
    • 5
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback